NCT04682106View on ClinicalTrials.gov

A Study of LY3493269 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

November 11, 2021

Study Completion Date

November 11, 2021

Conditions

Healthy

Interventions

DRUG

LY3493269

Administered orally.

DRUG

Placebo

Administered orally.

DRUG

Salcaprozate Sodium

Administered orally.

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY